Digital Therapeutics R&D

A leading DTx co-dev partner

We offer end-to-end DM & DTx co-dev partnerships

We are an entrepreneurial and multi-disciplinary team of digital health experts, behavioral designers, clinical researchers, software engineers, and data scientists with a track record of successful co-development partnerships with pharmas and startups.
Putting patient needs at the core of all our products, our methodology defines DTx and Digital Medicines products through a rigorous scientific analysis, commercial sustainability potential and strategic market fit.
All of our solutions are created exclusively in-house by our technical team, and proof of concepts and MVPs development is accelerated thanks to our proprietary DTx platform (H.Core).
Our capabilities and innovation offerings are augmented by an evolving “partner-ready” DTx solutions pipeline with some of our products having already reached full clinical validation.
We also maintain an evergreen Digital Health innovation offering, seeking out novel solutions in all therapeutic areas via our Healthware Ventures arm, and by investing in the acceleration of promising new startups.

BLOG

16/06/2021 | BlogPost

Virtual Reality treatment show significant improvement for Chronic Pain Patients

We are very excited to share the great results of the Orion Corporation Clinical Trial where Healthware was the key R&D partner creating a Digital Therapeutics solution (DTx) for chronic pain patients.

7/06/2021 | Point of viewPoint of view

Digital Therapeutics and Pharma: The Evolution of Partnerships Between Molecules and Software

Some key takeaways from the webinar by Healthware Labs and Plexus Ventures

12/04/2021 | BlogPost

Italy accelerates the path towards digital therapeutics implementation

PME talks to Roberto Ascione, CEO of Healthware Group, Gualberto Gussoni, Scientific Director of FADOI, Scientific Society of Internal Medicine and Giuseppe Recchia, Director of Tendenze Nuove about the advancement of digital therapeutics in Italy